Buy CJC-1295 no DAC Peptide Canada
Buy CJC-1295 No DAC, a synthetic peptide analogue of the growth hormone-releasing hormone (GHRH) that selectively stimulates growth hormone (GH) secretion from the anterior pituitary gland, making it a valuable tool for Canada researchers investigating its effects on metabolic health, body composition, and the physiological responses associated with GH dynamics.
Shop our Full Range of CJC-1295 no DAC Peptides
-
NEW
HGH Fragment 176-191 CJC-1295 No DAC Spray
£40.47 – £75.94 This product has multiple variants. The options may be chosen on the product page -
NEW
GHRP-6 CJC-1295 NO DAC Spray
£44.74 – £84.48 This product has multiple variants. The options may be chosen on the product page -
NEW
HGH Fragment 176-191 CJC-1295 no DAC
£32.47 – £40.27 This product has multiple variants. The options may be chosen on the product page -
SALE
SALE
SALE
NEWHexarelin CJC-1295 NO DAC Peptide Stack
£37.65 – £44.45 This product has multiple variants. The options may be chosen on the product page -
NEW
GHRP-6 CJC-1295 NO DAC
£36.74 – £43.54 This product has multiple variants. The options may be chosen on the product page -
SALE
SALE
SALE
GHRP-2 & CJC-1295 NO DAC Peptide Stack
£27.25 – £34.05 This product has multiple variants. The options may be chosen on the product page -
Ipamorelin & CJC-1295 No-Dac Blend 2.5mg Pre Mixed
£39.89 – £114.67 This product has multiple variants. The options may be chosen on the product page -
Ipamorelin CJC-1295 No Dac Blend Nasal Spray
£40.94 – £76.88 This product has multiple variants. The options may be chosen on the product page -
SALE
SALE
Ipamorelin CJC Without DAC Blend
£35.69 – £64.24 This product has multiple variants. The options may be chosen on the product page -
CJC-1295 No-Dac 2mg Pre Mixed
£24.74 – £69.22 This product has multiple variants. The options may be chosen on the product page -
CJC-1295 No-Dac Nasal Spray
£25.74 – £46.48 This product has multiple variants. The options may be chosen on the product page -
CJC-1295 No-Dac
£18.74 – £72.77 This product has multiple variants. The options may be chosen on the product page
What is CJC-1295 no DAC?
CJC-1295 no DAC is a peptide that stimulates the pituitary gland to boost growth hormone secretion, essential for growth, metabolism, and body composition. CJC-1295 no DAC is a Modified Growth Releasing Factor aminos 1-29, also known as Modified GRF (1-29).
While the natural form of GHRH has 44 amino acids, the truncated version called Sermorelin, or GRF 1-29, contains just 29 amino acids. Modified GRF (1-29) includes four substituted amino acids to enhance resistance against degradation and oxidation during production and in the body, also improving its binding affinity to GHRH receptors.
Mod GRF (1-29) is the portion of CJC-1295 DAC that is free from MPA, except for lysine. If lysine is present in a formulation labeled “CJC without DAC,” it shortens the peptide’s active lifespan, making it closer to Sermorelin in effect. Essentially, CJC no DAC is equivalent to Modified GRF (1-29) component.
CJC-1295 underwent further modification resulting in the addition of DAC (Drug Affinity Complex). This modification allows DAC to bind with a blood protein known as albumin, significantly extending its half-life to approximately eight days.
This peptide boosts growth hormone secretion similarly to others in its class but avoids common side effects like increased appetite and elevated cortisol, prolactin, acetylcholine, and aldosterone levels. This makes it an attractive choice for scientists seeking to optimize growth hormone production without unwanted hormonal fluctuations.
Buy CJC-1295 no DAC Nasal Spray, available in 15ml and 30ml glass spray bottles from Direct Peptides Canada.
CJC-1295 no DAC Mechanism Of Action
CJC-1295 No DAC operates primarily by mimicking the action of natural growth hormone-releasing hormone (GHRH), thereby facilitating the pulsatile release of growth hormone (GH) from the anterior pituitary gland.
This synthetic peptide binds to specific GHRH receptors located on the pituitary cells, triggering a cascade of intracellular signalling that leads to increased synthesis and secretion of GH. Elevated GH levels subsequently influence various physiological processes, including muscle growth, fat metabolism, and overall body composition.
The absence of the Drug Affinity Complex in CJC-1295 results in a shorter half-life, which allows researchers to investigate its acute effects on GH secretion and related metabolic pathways in a controlled manner. Canada Studies have demonstrated that this peptide can induce significant increases in serum GH levels, particularly when administered through subcutaneous injections.
Moreover, the regulation of GH secretion by CJC without Drug Affinity Complex is characterised by its ability to enhance the amplitude and frequency of GH pulses, clarifying its therapeutic potential in growth hormone deficient states and its role in optimising metabolic health. Understanding these mechanisms is crucial for future applications in research and clinical practice.
Source: PubChem
Structure of CJC-1295 no DAC
Sequence: H-DL-Tyr-DL-Ala-DL-Asp-DL-Ala-DL-xiIle-DL-Phe-DL-xiThr-DL-Gln-DL-Ser-DL-Tyr-DL-Arg-DL-Lys-DL-Val-DL-Leu-DL-Ala-DL-Gln-DL-Leu-DL-Ser-DL-Ala-DL-Arg-DL-Lys-DL-Leu-DL-Leu-DL-Gln-DL-Asp-DL-xiIle-DL-Leu-DL-Ser-DL-Arg-NH2
Molecular Formula: C152H252N44O42
Molecular Weight: 3367.9 g/mol
PubChem CID: 91976842
What Are The Research Benefits of CJC-1295 no DAC?
Pulsatile release of GH: to increase the amplitude and frequency of growth hormone pulses, closely resembling natural physiological processes.
Increased Muscle Growth: According to Canada studies, by stimulating the release of growth hormone, CJC without DAC can potentially enhance muscle mass and strength.
Fat Loss: Some studies suggest that CJC-1295 without Drug Affinity Complex may help reduce body fat by promoting lipolysis, the process where the body breaks down fats to use as energy.
Its metabolic regulation further supports its use in obesity management and improving metabolic health, making it a promising option for effective weight management.
Increased Bone Density: Growth hormone also plays a role in bone health. By stimulating its production, research on CJC without DAC indicates it may help increase bone density, reducing the risk of fractures and osteoporosis.
Cognition and Memory: Emerging Canada research suggests that the peptide may enhance cognition and memory by influencing growth hormone (GH) levels, which support neurogenesis and neuronal health. This is particularly important for aging populations experiencing cognitive decline.
Improved GH levels may enhance memory retention and learning, while better sleep quality from CJC without drug affinity complex could further aid cognitive function, offering benefits for both physical performance and mental acuity.
Enhanced Sleep Quality: Research suggests that CJC without DAC, an analogue of the growth hormone-releasing hormone (GHRH), may positively affect sleep patterns. By modulating the sleep-wake cycle, it has the potential to boost energy levels, offering a more restful and rejuvenating sleep experience.
Enhanced Skin Health: As we age, growth hormone production decreases, leading to signs of skin aging like wrinkles and reduced elasticity.
Canada Research suggests the peptide may help counter these effects by boosting growth hormone secretion, which supports cellular regeneration and collagen synthesis.
This GHRH peptide shows promise in anti-aging therapies, potentially offering firmer skin, improved elasticity, and fewer fine lines and wrinkles.
Wound Healing and Tissue Repair: Canada Studies suggest it may also play a significant role in wound healing and tissue health by stimulating gh secretion, which is crucial for cellular repair and regeneration.
It promotes fibroblast proliferation (the cells responsible for synthesising extracellular matrix and collagen), enhances nutrient transport, and improves metabolic function, supporting natural healing processes.
Canada Research suggests that GHRH analogs like CJC without the added drug affinity complex may accelerate recovery from injuries and improve tissue repair, potentially benefiting individuals with chronic healing conditions.
Promotion of Protein Synthesis: CJC-1295 without DAC research has demonstrated it can promote protein synthesis, a crucial process for muscle growth and recovery.
Potential Cardiovascular Benefits: Preliminary research suggests that the peptide may also positively affect cardiovascular health by modulating growth hormone levels, potentially improving heart function and reducing risk factors for heart attacks, such as inflammation and arterial stiffness.
Buy CJC-1295 no DAC Peptide Vial for research online today! This lyophilized product requires reconstitution with bacteriostatic water which you can purchase here along with other necessary supplies for laboratory use.
Buy CJC-1295 no DAC and Hexarelin Peptide Stack (Vials)
The combination of CJC-1295 No DAC and Hexarelin creates a powerful synergy for stimulating growth hormone (GH) release. CJC-1295 acts as a GHRH analogue, enhancing natural GH secretion, while Hexarelin targets the ghrelin receptor to boost GH levels and appetite. Together, they maximize GH production, supporting muscle growth, fat loss, recovery, and metabolic health.
You can buy CJC-1295 no DAC and Hexarelin Peptide Stack here online from Direct Peptides Canada.
For a full list of peptide stacks available from Direct Peptides Canada, visit the main Stacks page here.
Buy CJC-1295 No DAC and GHRP-6 Blend Peptide Nasal Spray
The CJC-1295 No DAC and GHRP-6 blend nasal spray combines two powerful peptides to boost growth hormone (GH) release in a pulsatile manner. CJC without DAC stimulates GH secretion from the pituitary gland, while GHRP-6 activates GH release via the ghrelin receptor.
This nasal spray provides a convenient delivery method for quick absorption, enhancing GH production and supporting muscle growth, fat loss, recovery, and metabolic health. Canada Clinical studies suggest it effectively prolongs GH effects while minimizing side effects associated with injections.
Buy CJC-1295 no DAC and GHRP-6 Blend Nasal Spray online here from Direct Peptides Canada
Frequently Asked Questions (FAQs) about CJC-1295 no DAC
How does CJC-1295 No DAC differ from CJC-1295 with DAC?
The key difference lies in the absence of the Drug Affinity Complex (DAC) in CJC-1295 No DAC. This results in a shorter half-life, allowing for more immediate control over its pharmacokinetics and effects on GH release, compared to its counterpart which has a prolonged duration of action.
What are the potential side effects of CJC without DAC?
Common side effects reported include transient hypotension, nausea, abdominal pain, diarrhea, itching, irritation at the injection site, erythema, and alterations in serum protein levels. It is essential for users to monitor their responses and consult with a healthcare provider if any severe side effects occur.
Can CJC-1295 No DAC Peptides Be Combined with Other Peptides?
Combining CJC with no added drug affinity complex with other peptides shows promise for better therapeutic outcomes, especially in growth hormone secretion, muscle recovery, and metabolic health. Research indicates that CJC with the drug affinity complex can be effectively paired with peptides like Ipamorelin or GHRP-6, which also stimulate GH release through different mechanisms.
This synergistic approach may enhance overall growth hormone levels, leading to improved body composition and faster muscle recovery. However, it’s important to assess potential interactions and side effects when combining these peptides to ensure safety and effectiveness.
Buy CJC-1295 no DAC and Ipamorelin Peptide Blend nasal spray here.
Is CJC-1295 No DAC Legal?
The legality of CJC-1295 No DAC varies by country and jurisdiction. In many regions, including the United States and Canada, the FDA (US Food and Drug Administration) has classified CJC without the drug affinity complex as a research chemical, meaning that while it may not be approved for human consumption or sale as a medication, it can be legally purchased for research purposes.
What research applications can CJC No DAC be used for?
CJC without Drug Affinity Complex can be employed in various research settings to study its effects on growth hormone dynamics, exploring its impact on muscle growth, fat metabolism, and overall metabolic health. Researchers may also investigate its potential benefits in conditions of growth hormone deficiency or related metabolic disorders.
How does CJC-1295 No DAC influence GH pulse characteristics?
CJC- without DAC is recognized for its ability to significantly enhance both the amplitude and frequency of growth hormone pulse releases. This modulation offers researchers a valuable opportunity to compare the physiological growth hormone release patterns with those typically seen in healthy adult populations.
Where is the best place to buy CJC-1295 no DAC peptides?
Direct Peptides Canada is a trusted and reliable supplier to buy cjc-1295 no DAC peptides from. They can guarantee 99% pure high quality cjc-1295 peptides for research at competitive prices.
Summary of Research Applications
- Pulsatile release of growth hormone.
- Promotion of protein synthesis
- Increased muscle growth and strength
- Enhanced metabolic function for fat loss
- Improved sleep
- Promotion of wound healing and tissue repair
- Neuroprotection and cognitive improvement
- Increased bone density
- Controlled pharmacokinetics for dosage optimisation
Buy CJC-1295 no DAC 2mg Pre-Mixed Pen, 99% pure from Direct Peptides Canada.
CJC-1295 no DAC Peptide Quality Assured
At Direct Peptides, we set a high standard for peptide solutions by providing CJC-1295 no DAC peptides with a guaranteed 99% purity. Our careful synthesis process ensures that every batch exceeds industry quality and effectiveness standards, showing our strong commitment to precision.
Our focus on purity enhances our reputation for quality and maximizes the therapeutic potential of CJC without Drug Affinity Complex. This commitment means our clients receive a product tailored to their research needs, offering reliable support for advanced studies and innovative uses.
When you choose to buy CJC no DAC peptides from us, you access a top-quality compound designed to enhance your research and provide valuable insights.
References For Further Reading
[1] S L Teichman, A Neale, B Lawrence, C Gagnon, JP Castaigne, and L A Frohman (2005) Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults – The Journal of Clinical Endocrinology and Metabolism, 2006 Mar, Volume 91 (Issue 3), Pages 799-805.
[2] M Ionescu and L A Frohman (2006) Pulsatile Secretion of Growth Hormone (GH) Persists during Continuous Stimulation by CJC-1295, a Long-Acting GH-Releasing Hormone Analog – The Journal of Clinical Endocrinology & Metabolism, Volume 91, Issue 12, 1 December 2006, Pages 4792–4797.
[3] M Alba, D Fintini, A Sagazio, B Lawrence, JP Castaigne, L A Frohman, R Salvatori (2006) Once-daily administration of CJC-1295, a long-acting growth hormone-releasing hormone (GHRH) analog, normalizes growth in the GHRH knockout mouse – American Journal of Physiology. Endocrinology and Metabolism, 2006 Dec, Volume 291 (Issue 6), Pages E1290-4.
[4] F Liao, T J Zhang, T E Mahan, H Jiang, and D M Holtzman (2015) Effects of growth hormone–releasing hormone on sleep and brain interstitial fluid amyloid-β in an APP transgenic mouse model – Brain, Behavior, and Immunity, Volume 47, July 2015, Pages 163-171.
[5] L Sackmann-Sala, J Ding, L A Frohman, J J Kopchick (2009) Activation of the GH/IGF-1 axis by CJC-1295, a long-acting GHRH analog, results in serum protein profile changes in normal adult subjects – Growth Hormone and IGF Research, 2009 Dec, Volume 19 (Issue 6), Pages 471-7.
[6] C Dieguez, V Jordan, P Harris, S Foord, M D Rodriguez-Arnao, A Gomez-Pan, R Hall, M F Scanlon (1986) Growth hormone responses to growth hormone-releasing factor (1-29) in euthyroid, hypothyroid and hyperthyroid rats. The Journal of Endocrinology, 1986 Apr, Volume 109 (Issue 1), Pages 53-6.
[7] R Valcavi, V Jordan, C Dieguez, R John, E Manicardi, I Portioli, M D Rodriguez-Arnao, A Gomez-Pan, R Hall, M F Scanlon (1986) Growth hormone responses to GRF 1-29 in patients with primary hypothyroidism before and during replacement therapy with thyroxine. Clinical Endocrinology (Oxford), 1986 Jun, Volume 24 (Issue 6), Pages 693-8.
[8] A V Schally, X Zhang, R Cai, J M Hare, R Granata, and M Bartoli (2019) Actions and Potential Therapeutic Applications of Growth Hormone-Releasing Hormone Agonists – Endocrinology, 2019 Jul 1, Volume 160 (Issue 7), Pages 1600-1612.
[9] T Ito, H Igarashi, T K Pradhan, W Hou, S A Mantey, J E Taylor, W A Murphy, D H Coy, and R T Jensen (2001) GI side-effects of a possible therapeutic GRF analogue in monkeys are likely due to VIP receptor agonist activity – Peptides, 2001 Jul, Volume 22 (Issue 7), Pages 1139-51.
Why Choose Direct Peptides Canada?
Buy CJC-1295 no DAC with a guaranteed 99% purity from Direct Peptides, your premier source for CJC peptides without Drug Affinity Complex. Our distinction lies in our handpicked selection of peptide formulations. Our inventory boasts peptide vials in concentrations of 2mg, 5mg, and 10mg, alongside innovative peptide blends and stacks for potential synergistic effects. Additionally, we offer convenient peptide nasal sprays in 15ml and 30ml sizes, and ready-to-use pre-mixed peptide pens. Direct Peptides is dedicated to meeting the varied needs of researchers, providing precise formulations required for their unique projects.
Direct Peptides is a chemical supplier, not a compounding pharmacy, and their peptides are not intended as prescription medications. These peptides are meant solely for laboratory purposes and are not for direct human consumption.
ALL CONTENT AND PRODUCT INFORMATION AVAILABLE ON THIS WEBSITE IS FOR EDUCATIONAL PURPOSES ONLY.
DISCLAIMER: These products are intended solely as a research chemical only. This classification allows for their use only for research development and laboratory studies. The information available on our Canada Direct Peptides website: https://canada.direct-peptides.com is provided for educational purposes only. These products are not for human or animal use or consumption in any manner. Handling of these products should be limited to suitably qualified professionals. They are not to be classified as a drug, food, cosmetic, or medicinal product and must not be mislabelled or used as such.
Related Posts
Peptide Therapy: Ipamorelin and CJC-1295
Fine out how these peptides can synergistically work together to enhance the individual effects
Synergistic Effects of HGH Fragment 176-191 and CJC-1295 No DAC Blend For Weight Loss
Discover how this blend enhances metabolic function to aid in weight loss.
Benefits of Hexarelin and CJC-1295 No DAC
Discover the potential benefits of this peptide stack for metabolic studies, including body composition and anti-aging.